Moderna (MRNA) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free MRNA Stock Alerts $148.59 -2.42 (-1.60%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 6:51 PM | marketbeat.comAdvanced Portfolio Management LLC Invests $598,000 in Moderna, Inc. (NASDAQ:MRNA)Advanced Portfolio Management LLC acquired a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,014 shares of the company's stock, valued at approximately $598,000. OtherJune 10 at 6:02 PM | benzinga.comModerna Submits Updated COVID-19 Jab to FDA for ReviewJune 10 at 6:36 AM | reuters.comModerna COVID/flu combo vaccine superior to separate shots in trialJune 10 at 6:30 AM | cnbc.comModerna's combination Covid, flu vaccine is more effective than existing shots in late-stage trialJune 10 at 5:50 AM | fool.comWhy Moderna Stock Is a No-Brainer Buy Right NowJune 9 at 4:32 AM | insidertrades.comNoubar Afeyan Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) StockJune 8 at 8:30 AM | insidertrades.comModerna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 SharesJune 8 at 7:18 AM | marketbeat.comPublic Employees Retirement Association of Colorado Sells 23,511 Shares of Moderna, Inc. (NASDAQ:MRNA)Public Employees Retirement Association of Colorado lowered its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 32.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 48,967 shares of the company's stock after sellinJune 8 at 6:45 AM | fool.com3 Reasons to Buy Moderna StockJune 7 at 10:23 PM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares of StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business's stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $151.25, for a total transaction of $2,268,750.00. Following the transaction, the director now directly owns 1,946,931 shares of the company's stock, valued at $294,473,313.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.June 7 at 3:03 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNAJune 7 at 3:03 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNAJune 7 at 9:38 AM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Bought by Pinebridge Investments L.P.Pinebridge Investments L.P. raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 22.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,993 shares of the company's stock after acquiring an addiJune 6, 2024 | marketbeat.comCibc World Markets Corp Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Cibc World Markets Corp boosted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 56.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 97,211 shares of the company's stock after purchasing an additional 35,154 shares during the period. CJune 6, 2024 | seekingalpha.comModerna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)June 5, 2024 | investorplace.comBiotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough PotentialJune 5, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNAJune 5, 2024 | marketbeat.comBank of Nova Scotia Has $4.55 Million Position in Moderna, Inc. (NASDAQ:MRNA)Bank of Nova Scotia boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 68.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,800 shares of the company's stock after buying an additional 18,574June 4, 2024 | marketbeat.comBelpointe Asset Management LLC Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA)Belpointe Asset Management LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 101.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,265 shares of the company's stock after pJune 4, 2024 | seekingalpha.comModerna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript)June 4, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) Receives "Hold" Rating from Needham & Company LLCJune 4, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) Price Target Raised to $160.00June 3, 2024 | insidermonkey.comIs Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?June 3, 2024 | marketbeat.comLingotto Investment Management LLP Has $23.18 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Lingotto Investment Management LLP boosted its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 233,095 shares of the company's stock after acquiriJune 3, 2024 | businesswire.comModerna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsJune 3, 2024 | proactiveinvestors.comModerna cancer vaccine's potential revealed in phase II dataJune 3, 2024 | cnbc.comModerna, Merck say vaccine improved survival in patients with deadly skin cancerJune 3, 2024 | reuters.comModerna-Merck skin cancer vaccine shows survival benefit in long-term follow-upJune 3, 2024 | marketbeat.comNeedham & Company LLC Reiterates "Hold" Rating for Moderna (NASDAQ:MRNA)Needham & Company LLC restated a "hold" rating on shares of Moderna in a research note on Monday.June 3, 2024 | fool.comIs Moderna Stock a Buy Now That It's a 2-Product Company?June 3, 2024 | americanbankingnews.comInsider Selling: Moderna, Inc. (NASDAQ:MRNA) Director Sells $2,901,600.00 in StockJune 3, 2024 | fool.comModerna Investors Just Got Some Bullish NewsJune 2, 2024 | marketbeat.comFocus Financial Network Inc. ADV Purchases Shares of 5,997 Moderna, Inc. (NASDAQ:MRNA)Focus Financial Network Inc. ADV acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,997 shares of the company's stockJune 1, 2024 | marketbeat.comAlberta Investment Management Corp Acquires 9,900 Shares of Moderna, Inc. (NASDAQ:MRNA)Alberta Investment Management Corp boosted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 11.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,725 shares oJune 1, 2024 | insidertrades.comNoubar Afeyan Sells 20,000 Shares of Moderna, Inc. (NASDAQ:MRNA) StockJune 1, 2024 | insidertrades.comStephen Hoge Sells 341 Shares of Moderna, Inc. (NASDAQ:MRNA) StockMay 31, 2024 | seekingalpha.comModerna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)May 31, 2024 | investors.comModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSKMay 31, 2024 | cnbc.comFDA approves Moderna's RSV vaccine for seniors, the company's second-ever productMay 31, 2024 | reuters.comUS FDA approves Moderna's RSV vaccine, its second marketed productMay 31, 2024 | investorplace.com3 Sorry Biotech Stocks to Sell in May While You Still CanMay 30, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 341 SharesModerna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 341 shares of Moderna stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $144.50, for a total transaction of $49,274.50. Following the completion of the transaction, the president now owns 1,471,777 shares in the company, valued at approximately $212,671,776.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.May 30, 2024 | fool.comWhy Moderna Stock Is Sinking This WeekMay 30, 2024 | investors.comModerna Pops After Confirming The U.S. Government Could Back Its Bird Flu VaccineMay 30, 2024 | insidertrades.comModerna, Inc. (NASDAQ:MRNA) CFO Sells $105,280.56 in StockMay 30, 2024 | marketbeat.comAdvisory Services Network LLC Buys 5,667 Shares of Moderna, Inc. (NASDAQ:MRNA)Advisory Services Network LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 80.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,715 shares of the company's stock after buying an additional 5,667 shareMay 30, 2024 | investorplace.com3 Nasdaq Stocks to Dump as They Near Peak PerformanceMay 30, 2024 | reuters.comUS nears deal to fund Moderna's bird flu vaccine trial, FT reportsMay 29, 2024 | marketbeat.comInsider Selling: Moderna, Inc. (NASDAQ:MRNA) CFO Sells $105,280.56 in StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) CFO James M. Mock sold 648 shares of the business's stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $162.47, for a total value of $105,280.56. Following the completion of the sale, the chief financial officer now owns 5,726 shares of the company's stock, valued at $930,303.22. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.May 29, 2024 | ca.news.yahoo.comArticle reported on rising cancer rates before pandemic, didn't link to vaccines | Fact check Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Check out WFC chart (Ad)I’m about to go head-to-head with Wall Street… Exposing one of their BEST kept secrets… A secret that they’ve kept hidden in the dark for YEARS… And according to the backtest, it’s already shown the power to pay out… 28%... 41%... Even 83%... Not in a year… Not in a month… But in just 24 hours… You gotta click here because I’m about to show how to spot what could be the next one. MRNA Media Mentions By Week MRNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.560.75▲Average Medical News Sentiment MRNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼2519▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Seagen News Amgen News Gilead Sciences News Biogen News BioNTech News argenx News Neurocrine Biosciences News Bio-Techne News Qiagen News Repligen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored